Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab

Risk Factors of Very Severe RSV Infections in a Multicenter Cohort of Very Preterm and Extreme Preterm Babies Receiving or Not Palivizumab

IntroductionPreterm infants are at risk of lower respiratory tract infections (LRTI), including Respiratory Syncytial Virus (RSV) associated bronchiolitis, for which palivizumab prophylaxis can be proposed. Our aim was to determine risk factors of very severe RSV disease in children born before 34 w...

Full description

Bibliographic Details
Main Authors: Gwenaelle Mulot, Mehdi Benchaib, Frank Plaisant, Dominique Ploin, Yves Gillet, Etienne Javouhey, Olivier Claris, Jean-Charles Picaud, Jean-Sebastien Casalegno, Marine Butin
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-07-01
Series:Frontiers in Pediatrics
Subjects:
cohort study
RSV
bronchiolitis
preterm
palivizumab
LRTI
Online Access:https://www.frontiersin.org/articles/10.3389/fped.2022.884120/full

Internet

https://www.frontiersin.org/articles/10.3389/fped.2022.884120/full

Similar Items